Weiqin Lin

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Superior Performance of N-Terminal Pro Brain Natriuretic Peptide for Diagnosis of Acute Decompensated Heart Failure in an Asian Compared with a Western Setting

Irwani Ibrahim, Win Sen Kuan, Chris Frampton et al. · European Journal of Heart Failure · 2016 · 38 citations · Full text

Medicine, Cardiology, Internal Medicine +4

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Minimally Invasive Biventricular Mechanical Circulatory Support with Impella Pumps as a Bridge to Heart Transplantation: A First-in-the-World Case Report

Kenneth D. Varian, Weining Xu, Weiqin Lin et al. · ESC Heart Failure · 2019 · 23 citations · Full text

Medicine, Cardiology, Surgery +17

Can Glucose-Lowering Medications Improve Outcomes in Non-Diabetic Heart Failure Patients? A Bayesian Network Meta-Analysis

Trevor James Jun‐Ming Yeong, Aaron Shengting, Oliver Lim et al. · ESC Heart Failure · 2022 · 22 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14